Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuh, J. C.L.
Right arrow Articles by Barone, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuh, J. C.L.
Right arrow Articles by Barone, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 30, No. 3, 390-393 (2002)
DOI: 10.1080/01926230252929963

Periosteal Hyperostosis (Exostosis) in DBA/1 Male Mice

Joann C.L. Schuh

Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA, schuhj{at}bainbridge.net

Randy Hall

Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA

Dina Lambert

Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA

Kim Harrington

Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA

Ken Mohler

Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA

Dauphine Barone

Immunex Corporation, 51 University Street, Seattle, Washington 98101, USA

Periosteal hyperostosis (exostosis) was identified in 5.9% (11/188) of DBA/1 male mice 10—14 weeks old used for collagen-induced arthritis (CIA) efficacy testing of immunomodulatory biologics. Mice with and without CIA in the affected limb, and also control and treated groups, were involved, with bilateral lesions in one mouse. Hyperostosis was characterized by circumferential and raised masses of variable location, length, and laterality, generally external to but occasionally breaching the periosteum of the metatarsals, metacarpals, tibia, femur, and humerus. Proportionally, the hyperostotic foci consisted of cancellous and woven bone, followed by osteoid, cartilage, and fibrous connective tissue and rarely infl ammatory cells. A displaced, presumably pathological fracture with callus formation was a concurrent lesion in only one case. Tartrate-resistant acid phosphatase-positive cells were frequent at bony interfaces, indicating an active resorptive process. Periosteal hyperostosi s is an incidental and potentially common finding in DBA/1 mice. Underreporting may occur due to the male bias in disease expression of this CIA model, sampling bias (generally paws only), tissue obliteration in the presence of CIA, and lack of comprehensive historical data on the background and aging lesions in this strain of mouse. Identification of such confounding bony lesions is important to the interpretation of efficacy studies, and suggests the need to further examine the biology of bone development in this strain of mouse.

Key Words: Animal model of human disease • efficacy study • murine collagen-induced arthritis • musculoskeletal pathology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?